deltatrials
Completed PHASE3 NCT00000585

Penicillin Prophylaxis in Sickle Cell Disease (PROPS)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Anemia, Sickle Cell Hematologic Diseases Hemoglobinopathies Infection (S. Pneumoniae) Pneumonia
Interventions penicillin
Updated 5 times since 2017 Last updated: Mar 24, 2016 Started: Aug 31, 1983 Completion: Oct 31, 1994

This PHASE3 trial investigates Anemia, Sickle Cell and Hematologic Diseases and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 5 recorded versions since 1983 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Aug 1983

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.